[1] LEE JJ,PARK S,PARK H,et al.Tracing oncogene rearrangements in the mutational history of lung adenocarcinoma［J］.Cell,2019,177(7):1842-1857.
[2] SUNG H,FERLAY J,SIEGEL RL,et al.Global cancer statistics 2020:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries［J］.CA Cancer J Clin,2021,71(3):209-249.
[3] MAO Y,YANG D,HE J,et al.Epidemiology of lung cancer［J］.Surg Oncol Clin N Am,2016,25(3):439-445.
[4] LI N,ZHAN X.Identification of pathology-specific regulators of m6A RNA modification to optimize lung cancer management in the context of predictive,preventive,and personalized medicine［J］.EPMA J,2020,11(3):485-504.
[5] BIRD A.Perceptions of epigenetics［J］.Nature,2007,447(7143):396-398.
[6] YUE Y,LIU J,HE C.RNA N6-methyladenosine methylation in post-transcriptional gene expression regulation［J］.Genes Dev,2015,29(13):1343-1355.
[7] JIA G,FU Y,HE C.Reversible RNA adenosine methylation in biological regulation［J］.Trends Genet,2013,29(2):108-115.
[8] ROUNDTREE IA,EVANS ME,PAN T,et al.Dynamic RNA modifications in gene expression regulation［J］.Cell,2017,169(7):1187-1200.
[9] ZHAO BS,ROUNDTREE IA,HE C.Post-transcriptional gene regulation by mRNA modifications［J］.Nat Rev Mol Cell Biol,2017,18(1):31-42.
[10] DOMINISSINI D,MOSHITCH-MOSHKOVITZ S,SCHWARTZ S,et al.Topology of the human and mouse m6A RNA methylomes revealed by m6A-seq［J］.Nature,2012,485(7397):201-206.
[11] MEYER KD,SALETORE Y,ZUMBO P,et al.Comprehensive analysis of mRNA methylation reveals enrichment in 3' UTRs and near stop codons［J］.Cell,2012,149(7):1635-1646.
[12] SHI H,WANG X,LU Z,et al.YTHDF3 facilitates translation and decay of N6-methyladenosine-modified RNA［J］.Cell Res,2017,27(3):315-328.
[13] BOKAR JA,SHAMBAUGH ME,POLAYES D,et al.Purification and cDNA cloning of the AdoMet-binding subunit of the human mRNA (N6-adenosine)-methyltransferase［J］.RNA,1997,3(11):1233-1247.
[14] LIU J,YUE Y,HAN D,et al.A METTL3-METTL14 complex mediates mammalian nuclear RNA N6-adenosine methylation［J］.Nat Chem Biol,2014,10(2):93-95.
[15] PING XL,SUN BF,WANG L,et al.Mammalian WTAP is a regulatory subunit of the RNA N6-methyladenosine methyltransferase［J］.Cell Res,2014,24(2):177-189.
[16] PATIL DP,CHEN CK,PICKERING BF,et al.m6A RNA methylation promotes XIST-mediated transcriptional repression［J］.Nature,2016,537(7620):369-373.
[17] KNUCKLES P,LENCE T,HAUSSMANN IU,et al.Zc3h13/Flacc is required for adenosine methylation by bridging the mRNA-binding factor Rbm15/Spenito to the m6A machinery component Wtap/Fl(2)d［J］.Genes Dev,2018,32(5-6):415-429.
[18] SLEDZ P,JINEK M.Structural insights into the molecular mechanism of the m6A writer complex［J］.Elife,2016,5:e18434.
[19] WARDA AS,KRETSCHMER J,HACKERT P,et al.Human METTL16 is a N6-methyladenosine (m6A) methyltransferase that targets pre-mRNAs and various non-coding RNAs［J］.EMBO Reports,2017,18(11):2004-2014.
[20] SHIMA H,MATSUMOTO M,ISHIGAMI Y,et al.S-adenosylmethionine synthesis is regulated by selective N6-adenosine methylation and mRNA degradation involving METTL16 and YTHDC1［J］.Cell Rep,2017,21(12):3354-3363.
[21] GERKEN T,GIRARD CA,TUNG YC,et al.The obesity-associated FTO gene encodes a 2-oxoglutarate-dependent nucleic acid demethylase［J］.Science,2007,318(5855):1469-1472.
[22] LOOS RJ,BOUCHARD C.FTO:the first gene contributing to common forms of human obesity［J］.Obes Rev,2008,9(3):246-250.
[23] LOOS RJ,YEO GS.The bigger picture of FTO:the first GWAS-identified obesity gene［J］.Nat Rev Endocrinol,2014,10(1):51-61.
[24] FU Y,JIA G,PANG X,et al.FTO-mediated formation of N6-hydroxymethyladenosine and N6-formyladenosine in mammalian RNA［J］.Nat Commun,2013,4:1798.
[25] JIA G,FU Y,ZHAO X,et al.N6-methyladenosine in nuclear RNA is a major substrate of the obesity-associated FTO［J］.Nat Chem Biol,2011,7(12):885-887.
[26] ZHENG G,DAHL JA,NIU Y,et al.ALKBH5 is a mammalian RNA demethylase that impacts RNA metabolism and mouse fertility［J］.Mol Cell,2013,49(1):18-29.
[27] UEDA Y,OOSHIO I,FUSAMAE Y,et al.AlkB homolog 3-mediated tRNA demethylation promotes protein synthesis in cancer cells［J］.Sci Rep,2017,7:42271.
[28] IYER LM,TAHILIANI M,RAO A,et al.Prediction of novel families of enzymes involved in oxidative and other complex modifications of bases in nucleic acids［J］.Cell Cycle,2009,8(11):1698-1710.
[29] LIAO S,SUN H,XU C.YTH domain:a family of N6-methyladenosine (m6A) readers［J］.Genomics Proteomics Bioinformatics,2018,16(2):99-107.
[30] BALACCO DL,SOLLER M.The m6A writer:rise of a machine for growing tasks［J］.Biochemistry,2019,58(5):363-378.
[31] DU H,ZHAO Y,HE J,et al.YTHDF2 destabilizes m6A-containing RNA through direct recruitment of the CCR4-NOT deadenylase complex［J］.Nat Commun,2016,7:12626.
[32] WANG X,ZHAO BS,ROUNDTREE IA,et al.N6-methyladenosine modulates messenger RNA translation efficiency［J］.Cell,2015,161(6):1388-1399.
[33] LIANG Y,ZHAN G,CHANG KJ,et al.The roles of m6A RNA modifiers in human cancer［J］.J Chin Med Assoc,2020,83(3):221-226.
[34] LI A,CHEN YS,PING XL,et al.Cytoplasmic m6A reader YTHDF3 promotes mRNA translation［J］.Cell Res,2017,27(3):444-447.
[35] ROUNDTREE IA,HE C.Nuclear m6A reader YTHDC1 regulates mRNA splicing［J］.Trends Genet,2016,32(6):320-321.
[36] LIU N,DAI Q,ZHENG G,et al.N6-methyladenosine-dependent RNA structural switches regulate RNA-protein interactions［J］.Nature,2015,518(7540):560-564.
[37] HUANG H,WENG H,SUN W,et al.Recognition of RNA N6-methyladenosine by IGF2BP proteins enhances mRNA stability and translation［J］.Nat Cell Biol,2018,20(3):285-295.
[38] LIN Z,HSU PJ,XING X,et al.Mettl3-/Mettl14-mediated mRNA N6-methyladenosine modulates murine spermatogenesis［J］.Cell Res,2017,27(10):1216-1230.
[39] ZHOU J,WAN J,GAO X,et al.Dynamic m6A mRNA methylation directs translational control of heat shock response［J］.Nature,2015,526(7574):591-594.
[40] LI HB,TONG J,ZHU S,et al.m6A mRNA methylation controls T cell homeostasis by targeting the IL-7/STAT5/SOCS pathways［J］.Nature,2017,548(7667):338-342.
[41] VISVANATHAN A,PATIL V,ARORA A,et al.Essential role of METTL3-mediated m6A modification in glioma stem-like cells maintenance and radioresistance［J］.Oncogene,2018,37(4):522-533.
[42] CUI Q,SHI H,YE P,et al.m6A RNA methylation regulates the self-renewal and tumorigenesis of glioblastoma stem cells［J］.Cell Rep,2017,18(11):2622-2634.
[43] ZHANG C,SAMANTA D,LU H,et al.Hypoxia induces the breast cancer stem cell phenotype by HIF-dependent and ALKBH5-mediated m6A-demethylation of NANOG mRNA［J］.Proc Natl Acad Sci USA,2016,113(14):E2047-E2056.
[44] LIU J,ECKERT MA,HARADA BT,et al.m6A mRNA methylation regulates AKT activity to promote the proliferation and tumorigenicity of endometrial cancer［J］.Nat Cell Biol,2018,20(9):1074-1083.
[45] ZHOU J,WANG J,HONG B,et al.Gene signatures and prognostic values of m6A regulators in clear cell renal cell carcinoma - a retrospective study using TCGA database［J］.Aging (Albany NY),2019,11(6):1633-1647.
[46] BROWER V.Afatinib and chemotherapy in non-small-cell lung cancer［J］.Lancet Oncol,2016,17(2):e47.
[47] DIAO MN,ZHANG XJ,ZHANG YF.The critical roles of m6A RNA methylation in lung cancer:from mechanism to prognosis and therapy［J］.Br J Cancer,2023,129(1):8-23.
[48] ZHANG Q,XU K.The role of regulators of RNA m6A methylation in lung cancer［J］.Genes Dis,2023,10(2):495-504.
[49] LI D,CHEN T,LI QG.Identification of a m6A-related ferroptosis signature as a potential predictive biomarker for lung adenocarcinoma［J］.BMC Pulm Med,2023,23(1):128.
[50] ZHANG Y,LIU X,LIU L,et al.Expression and prognostic significance of m6A-related genes in lung adenocarcinoma［J］.Med Sci Monit,2020,26:e919644.
[51] ZHUANG Z,CHEN L,MAO Y,et al.Diagnostic,progressive and prognostic performance of m6A methylation RNA regulators in lung adenocarcinoma［J］.Int J Biol Sci,2020,16(11):1785-1797.
[52] ZHU J,WANG M,HU D.Deciphering N6-methyladenosine-related genes signature to predict survival in lung adenocarcinoma［J］.Biomed Res Int,2020,2020:2514230.
[53] DING Y,QI N,WANG K,et al.FTO facilitates lung adenocarcinoma cell progression by activating cell migration through mRNA demethylation［J］.Onco Targets Ther,2020,13:1461-1470.
[54] GUO W,HUAI Q,WAN H,et al.Prognostic impact of IGF2BP3 expression in patients with surgically resected lung adenocarcinoma［J］.DNA Cell Biol,2021,40(2):316-331.
[55] XU F,ZHANG H,CHEN J,et al.Immune signature of T follicular helper cells predicts clinical prognostic and therapeutic impact in lung squamous cell carcinoma［J］.Int Immunopharmacol,2020,81:105932.
[56] LIU J,REN D,DU Z,et al.m6A demethylase FTO facilitates tumor progression in lung squamous cell carcinoma by regulating MZF1 expression［J］.Biochem Biophys Res Commun,2018,502(4):456-464.
[57] SHARMA SV,LEE DY,LI B,et al.A chromatin-mediated reversible drug-tolerant state in cancer cell subpopulations［J］.Cell,2010,141(1):69-80.
[58] MURDOCK CC,MOLLER-JACOBS LL,THOMAS MB.Complex environmental drivers of immunity and resistance in malaria mosquitoes［J］.Proc Biol Sci,2013,280(1770):20132030.
[59] FONSECA JD,KNIGHT GM,MCHUGH TD.The complex evolution of antibiotic resistance in mycobacterium tuberculosis［J］.Int J Infect Dis,2015,32:94-100.
[60] MENG Q,WANG S,ZHOU S,et al.Dissecting the m6A methylation affection on afatinib resistance in non-small cell lung cancer［J］.Pharmacogenomics J,2020,20(2):227-234.
[61] WANG D,LIPPARD SJ.Cellular processing of platinum anticancer drugs［J］.Nat Rev Drug Discov,2005,4(4):307-320.
[62] ZHANG Y,HAN CY,DUAN FG,et al.p53 sensitizes chemoresistant non-small cell lung cancer via elevation of reactive oxygen species and suppression of EGFR/PI3K/AKT signaling［J］.Cancer Cell Int,2019,19:188.
[63] JIN D,GUO J,WU Y,et al.m6A mRNA methylation initiated by METTL3 directly promotes YAP translation and increases YAP activity by regulating the MALAT1-miR-1914-3p-YAP axis to induce NSCLC drug resistance and metastasis［J］.J Hematol Oncol,2019,12(1):135.
[64] WANG X,HU Y,LI X,et al.YTHDC2-mediated m6A mRNA modification of Id3 suppresses cisplatin resistance in non-small cell lung cancer［J］.J Thorac Dis,2023,15(3):1247-1257.
[65] DING N,YOU A,TIAN W,et al.Chidamide increases the sensitivity of non-small cell lung cancer to crizotinib by decreasing c-MET mRNA methylation［J］.Int J Biol Sci,2020,16(14):2595-2611.
[66] LIN S,CHOE J,DU P,et al.The m6A methyltransferase METTL3 promotes translation in human cancer cells［J］.Mol Cell,2016,62(3):335-345.
[67] CHOE J,LIN S,ZHANG W,et al.mRNA circularization by METTL3-eIF3h enhances translation and promotes oncogenesis［J］.Nature,2018,561(7724):556-560.
[68] CHEN WW,QI JW,HANG Y,et al.Simvastatin is beneficial to lung cancer progression by inducing METTL3-induced m6A modification on EZH2 mRNA［J］.Eur Rev Med Pharmacol Sci,2020,24(8):4263-4270.
[69] DING Y,QI N,WANG K,et al.FTO facilitates lung adenocarcinoma cell progression by activating cell migration through mRNA demethylation［J］.Onco Targets Ther,2020,13:1461-1470.
[70] LI J,HAN Y,ZHANG H,et al.The m6A demethylase FTO promotes the growth of lung cancer cells by regulating the m6A level of USP7 mRNA［J］.Biochem Biophys Res Commun,2019,512(3):479-485.
[71] SHI H,ZHAO J,HAN L,et al.Retrospective study of gene signatures and prognostic value of m6A regulatory factor in non-small cell lung cancer using TCGA database and the verification of FTO［J］.Aging (Albany NY),2020,12(17):17022-17037.
[72] ZHANG S,ZHAO BS,ZHOU A,et al.m6A demethylase ALKBH5 maintains tumorigenicity of glioblastoma stem-like cells by sustaining FOXM1 expression and cell proliferation program［J］.Cancer Cell,2017,31(4):591-606.
[73] XIE Q,WU TP,GIMPLE RC,et al.N6-methyladenine DNA modification in glioblastoma［J］.Cell,2018,175(5):1228-1243.
[74] CHAO Y,SHANG J,JI W.ALKBH5-m6A-FOXM1 signaling axis promotes proliferation and invasion of lung adenocarcinoma cells under intermittent hypoxia［J］.Biochem Biophys Res Commun,2020,521(2):499-506.
[75] SHENG H,LI Z,SU S,et al.YTH domain family 2 promotes lung cancer cell growth by facilitating 6-phosphogluconate dehydrogenase mRNA translation［J］.Carcinogenesis,2020,41(5):541-550.